Diagnostic Strategy for the Detection of Dystrophin Gene Mutations in Asian Patients and Carriers Using Immortalized Cell Lines

Abstract

Duchenne muscular dystrophy and Becker muscular dystrophy are X-linked recessive diseases of muscle degeneration caused by mutations in the dystrophin gene. More than half of our local Asian patients have point mutations that cannot be detected by conventional multiplex polymerase chain reaction deletion screening. This study aimed to develop mutational screening and carrier detection for Duchenne and Becker muscular dystrophy using protein truncation analysis from Epstein-Barr virus—transformed lymphocyte cell lines. Messenger ribonucleic acid was extracted from fresh lymphocytes and Epstein-Barr virus—transformed lymphocyte cell lines of 14 patients. Reverse transcriptase polymerase chain reaction was performed in 11 overlapping segments, followed by in vitro protein translation and truncation analysis. DNA sequencing was carried out for the corresponding complementary DNA regions, which showed aberrant truncated protein products. Carrier studies using this method were also performed for two families. Half of the patients had frame-shifting deletions, and the remaining seven patients showed point mutations, of which four were novel. These mutations were detected in messenger ribonucleic acid extracted from both fresh lymphocytes and Epstein-Barr virus—transformed lymphocyte cell lines. Carrier status was confirmed in one family and was found to be negative in the other family studied. Protein truncation analysis is an efficient method of screening truncating point mutations from immortalized lymphocyte cell lines from patients. This approach not only serves to prove the pathogenicity of both deletion- and nondeletion-type mutations; it is also effective for carrier detection. The use of such cell lines obviates the need for repeated blood and muscle sampling in patients and offers a perpetual source of messenger ribonucleic acid that can be used long after the patient's demise. (J Child Neurol 2006;21:150—155; DOI 10.2310/7010.2006.00029).

Get full access to this article

View all access options for this article.

References

Emery AE : Population frequencies of inherited neuromuscular diseases—A world survey . Neuromuscul Disord 1991;1:19—29.

Koenig M. , Hoffman EP , Bertelson CJ , et al: Complete cloning of the Duchenne muscular dystrophy cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals . Cell 1987;50:509—517.

Den Dunnen JT , Grootscholten PM , Bakker E. , et al: Topography of the Duchenne muscular dystrophy gene: FIGE and cDNA analysis of 194 cases reveals 115 deletions and 13 duplications. Am J Hum Genet 1989;45:835—847.

Chamberlain JS , Gibbs RA , Rainer JE , et al: Deletion screening of the Duchenne muscular dystrophy locus via multiplex DNA amplification. Nucleic Acids Res 1988;16:11141—11156.

Beggs AH , Koenig M. , Boyce FM , Kunkel LM : Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990;86:45—48.

Lai PS , Takeshima Y. , Adachi K. , et al: Comparative study on deletions of the dystrophin gene in three Asian populations. Hum Genet 2002;47:552—555.

Low PS , Lai PS , Lee WL , et al: Molecular diagnosis of Duchenne muscular dystrophy in Singapore . Ann Acad Med Singapore 1996;25:84—89.

Katayama S. , Takeshita N. , Yano T. , et al: Prenatal diagnosis of Duchenne's muscular dystrophy analysis by polymerase chain reaction analysis. Fetal Diagn Ther 1994;9:379—384.

Tuffery S. , Chambert S. , Bareil C. , et al: Mutation analysis of the dystrophin gene in Southern French DMD or BMD families: From Southern blot to protein truncation test. Hum Genet 1998;102:334—342.

10.

Roest PA , Roberts RG , van der Tuijin AC , et al: Protein truncation test (PTT) for rapid detection of translation-terminating mutations. Hum Mol Genet 1993;2:1719—1721.

11.

Den Dunnen JT , Van Ommen GJB : The protein truncation test: A review . Hum Mutat 1999;14:95—102.

12.

Tennyson CN , Shi Q. , Worton RG : Stability of the human dystrophin transcript in muscle. Nucleic Acids Res 1996;24:3059—3064.

13.

Roberts RG , Barby Tfm , Manners E. , et al: Direct detection of dystrophin gene rearrangements by analysis of dystrophin mRNA in peripheral blood lymphocytes. Am J Hum Genet 1991;49:298—310.

14.

Sambrook J. , Russel DW : Molecular Cloning: A Laboratory Manual, 3rd ed. Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 2001.

15.

Kaplan JC , Kahn A. , Chelly J. : Illegitimate transcription: Its use in the study of inherited disease. Hum Mutat 1992;1:357—360.

16.

Nishio H. , Matsuo M. , Kitoh Y. , et al: Brain- and muscle-type promoters of the dystrophin gene are selected in peripheral lymphocytes and Epstein Barr virus-transformed lymphoblastoid cells. J Neurol 1993;241:81—86.

17.

Gardner RJ , Bobrow M. , Roberts RG : The identification of point mutations in Duchenne muscular dystrophy patients by using reverse-transcription PCR and the protein truncation test. Am J Hum Genet 1995;57:311—320.

18.

Whittock NV , Roberts RG , Mathew CG , Abbs SJ : Dystrophin point mutation screening using a multiplexed protein truncation test. Genet Test 1997;1:115—123.

19.

Nigro G. , Politano L. , Nigro V. , et al: Mutation of dystrophin gene and cardiomyopathy. Neuromuscul Disord 1994;4:371—379.

20.

Roberts RG , Bobrow M. , Bentley DR : Point mutations in the dystrophin gene. Proc Natl Acad Sci U S A 1992;89:2331—2335.

21.

Prior TW , Bartolo C. , Pearl DK , et al: Spectrum of small mutations in the dystrophin coding region . Am J Hum Genet 1995;57:22—33.

22.

Cargill M. , Altshuler D. , Ireland J. , et al: Characterization of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 1999;22:231—238.

23.

Hofstra Rmw , Mulder IM , Vossen R. , et al: DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients. Hum Mutat 2004;23:57—66.

24.

Rininsland F. , Hahn A. , Niemann-Seyde S. , et al: Identification of a new DMD gene deletion by ectopic transcript analysis. J Med Genet 1992;29:647—651.